Healthcare Services Group, Inc. (HCSG)

NASDAQIndustrialsMedical - Care FacilitiesSnapshot 2026-10-23

$25.30+2.06%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Healthcare Services Group, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.8%

+10% or more+5%0%−5%−10% or less

1.23 → 1.24 EPS · FY ending Dec 31, 2027 · 5 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	530.42M
EPS	—	0.264
FY 2026 · Annual
Revenue	$470.8M	1.94B
EPS	—	1.306
FY 2027 · Annual
Revenue	—	2.16B
EPS	—	1.241

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Free cash flow near $77.5M	The company has strong cash flow near $77.5M.	Intact	Free cash flow falls below $70M in FY25	Free cash flow: $23.168M FY2026-Q2; GAAP. Published target: Free cash flow >= $70M in FY25. Target period is not explicitly aligned with this observation. Source published Jul 24, 202623,168,000 USD · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Increase operating income	Operating income rose from $23.9M to $34.5M in one year.	Intact	Operating income falls below $25M in any quarter of FY26	Operating income: $22.209M FY2026-Q2; GAAP. Published target: Operating income >= $34.5M in FY26-Q1 equivalent. Target period is not explicitly aligned with this observation. Source published Jul 24, 202622,209,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Mid-single-digit revenue growth	A primary condition in Healthcare Services Group, Inc.'s published investment case. The stated target is >=6% YoY revenue growth.	Broken	YoY revenue growth falls below 4% in FY26	Revenue growth: 3.29% FY2026-Q3; GAAP. Published target: >=6% YoY revenue growth. Target period is not explicitly aligned with this observation. Source published Oct 23, 20263.287691 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Sep 30, 2026 Source: company_financial_results. Reference: ab6605fc-3a53-4c3b-8581-b0a2843fb25e. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$1.24

$1.16 → $1.24 · observed estimates

FY2027 revenue$2.16B

$2.04B → $2.16B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$1.16	$2,036,953,520	6 / 6
2026-07-25	Unavailable	Unavailable	4 / 4
2026-07-26	Unavailable	Unavailable	3 / 4
2026-07-27	Unavailable	Unavailable	3 / 4
2026-07-28	Unavailable	Unavailable	3 / 4
2026-07-29	$1.22	$2,033,556,990	6 / 6
2026-07-30	$1.22	$2,033,556,990	6 / 6
2026-07-31	$1.22	$2,033,556,990	6 / 6
2026-08-01	Unavailable	Unavailable	4 / 4
2026-08-02	Unavailable	Unavailable	4 / 4
2026-08-03	$1.22	$2,033,556,990	6 / 6
2026-08-04	$1.22	$2,033,556,990	6 / 6
2026-08-05	$1.23	$2,029,106,990	6 / 6
2026-08-06	$1.23	$2,029,106,990	6 / 6
2026-08-07	Unavailable	Unavailable	4 / 4
2026-08-08	$1.23	$2,029,106,990	6 / 6
2026-08-09	$1.23	$2,029,106,990	6 / 6
2026-08-10	$1.23	$2,029,106,990	6 / 6
2026-08-12	$1.23	$2,029,106,990	6 / 6
2026-08-13	Unavailable	Unavailable	4 / 4
2026-08-14	Unavailable	Unavailable	4 / 4
2026-08-15	Unavailable	Unavailable	4 / 4
2026-08-16	Unavailable	Unavailable	4 / 4
2026-08-17	Unavailable	Unavailable	4 / 4
2026-08-18	Unavailable	Unavailable	4 / 4
2026-08-19	Unavailable	Unavailable	4 / 4
2026-08-20	Unavailable	Unavailable	4 / 4
2026-08-21	Unavailable	$2,033,550,619	4 / 5
2026-08-22	$1.23	$2,033,550,619	5 / 5
2026-08-23	$1.23	$2,033,550,619	5 / 5
2026-08-24	$1.23	$2,033,550,619	5 / 5
2026-08-25	$1.23	$2,033,550,619	5 / 5
2026-08-26	$1.23	$2,033,550,619	5 / 5
2026-08-27	$1.23	$2,033,550,619	5 / 5
2026-08-28	$1.23	$2,033,550,619	5 / 5
2026-08-29	$1.23	$2,033,550,619	5 / 5
2026-08-30	$1.23	$2,033,550,619	5 / 5
2026-08-31	$1.23	$2,033,550,619	5 / 5
2026-09-01	$1.23	$2,033,550,619	5 / 5
2026-09-02	$1.23	$2,033,550,619	5 / 5
2026-09-03	$1.23	$2,033,550,619	5 / 5
2026-09-04	$1.23	$2,033,550,619	5 / 5
2026-09-05	$1.23	$2,033,550,619	5 / 5
2026-09-06	$1.23	$2,033,550,619	5 / 5
2026-09-07	$1.23	$2,033,550,619	5 / 5
2026-09-08	$1.23	$2,033,550,619	5 / 5
2026-09-09	$1.23	$2,033,550,619	5 / 5
2026-09-10	$1.23	$2,033,550,619	5 / 5
2026-09-11	$1.23	$2,033,550,619	5 / 5
2026-09-12	$1.23	$2,033,550,619	5 / 5
2026-09-13	$1.23	$2,033,550,619	5 / 5
2026-09-14	$1.23	$2,033,550,619	5 / 5
2026-09-15	$1.23	$2,033,550,619	5 / 5
2026-09-16	$1.23	$2,033,550,619	5 / 5
2026-09-17	$1.23	$2,033,550,619	5 / 5
2026-09-18	$1.23	$2,033,550,619	5 / 5
2026-09-19	$1.23	$2,033,550,619	5 / 5
2026-09-20	$1.23	$2,033,550,619	5 / 5
2026-09-21	$1.23	$2,033,550,619	5 / 5
2026-09-22	$1.23	$2,033,550,619	5 / 5
2026-09-23	$1.23	$2,033,550,619	5 / 5
2026-09-24	$1.23	$2,033,550,619	5 / 5
2026-09-25	$1.23	$2,033,550,619	5 / 5
2026-09-26	$1.23	$2,033,550,619	5 / 5
2026-09-27	$1.23	$2,033,550,619	5 / 5
2026-09-28	$1.23	$2,033,550,619	5 / 5
2026-09-29	$1.23	$2,033,550,619	5 / 5
2026-09-30	$1.23	$2,033,550,619	5 / 5
2026-10-01	$1.23	$2,033,550,619	5 / 5
2026-10-02	$1.23	$2,033,550,619	5 / 5
2026-10-03	$1.23	$2,033,550,619	5 / 5
2026-10-04	$1.23	$2,033,550,619	5 / 5
2026-10-05	$1.23	$2,033,550,619	5 / 5
2026-10-06	$1.23	$2,033,550,619	5 / 5
2026-10-07	$1.23	$2,033,552,333	5 / 5
2026-10-08	$1.22	$2,055,302,333	5 / 5
2026-10-09	$1.22	$2,055,302,333	5 / 5
2026-10-10	$1.22	$2,055,302,333	5 / 5
2026-10-11	$1.22	$2,055,302,333	5 / 5
2026-10-12	$1.22	$2,055,302,333	5 / 5
2026-10-13	$1.22	$2,055,302,333	5 / 5
2026-10-14	$1.22	$2,055,302,333	5 / 5
2026-10-15	$1.22	$2,055,302,333	5 / 5
2026-10-16	$1.22	$2,055,302,333	5 / 5
2026-10-17	$1.22	$2,055,302,333	5 / 5
2026-10-18	$1.22	$2,055,302,333	5 / 5
2026-10-19	$1.22	$2,055,302,333	5 / 5
2026-10-20	$1.22	$2,055,302,333	5 / 5
2026-10-21	$1.22	$2,055,302,333	5 / 5
2026-10-22	$1.24	$2,115,020,133	5 / 5
2026-10-23	$1.24	$2,136,017,107	5 / 5
2026-10-24	$1.24	$2,158,231,393	5 / 5

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	3	3
2026-06-01	3	3
2026-07-01	3	3
2026-08-01	4	3
2026-09-01	4	3
2026-10-01	4	3

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 4 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 1 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Robert W. BairdOct 8

$24.00New observation · no comparable prior

$0$13.20$26.40

0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Free cash flow near $77.5MFree cash flow: $23.168M
Increase operating incomeOperating income: $22.209M
Mid-single-digit revenue growthPublished status: Broken

Next proof point

Next earnings date unavailable

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.1%Typical daily move · historical

Downside history

-19.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Healthcare Services Group, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

HCSG is a growth-oriented services business with a recent improvement in financial performance, but elevated risks make the thesis less settled than a durable compounder. The long-term thesis is intact this month, supported by recent results, though cost control remains mixed.

What's priced into Healthcare Services Group, Inc.

The valuation evidence is mixed: HCSG is described as cheap versus peers, while the model also shows a 0.61 premium versus peers. The priced-in tag is justified, with low fragility and an expectations gap of -0.19, so the evidence does not point to extreme expectations or a highly fragile setup.

What the fundamentals likely do

Near term, revenue growth has momentum: third-quarter revenue rose year over year, and management raised its 2027 revenue growth outlook to low double-digits. Cost of services increased as a share of revenue, while adjusted SG&A stayed within its stated range; the sector backdrop is a headwind, and past deep misses leave some execution risk despite the low near-term miss assessment.

What Healthcare Services Group, Inc. hinges on

Over the next few quarters, the thesis depends on HCSG sustaining revenue growth while bringing service costs under control. A guidance cut would be a meaningful negative; continued earnings strength and higher guidance from sector bellwether GMRS would support the sector backdrop, while weakness at GMRS could remove that support.